MENU

TARA Protara Therapeutics Forecast, Technical & Fundamental Analysis

a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.

Industry Biotechnology
TARA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
TARA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TARA is expected to report earnings to rise 11.11% to -50 cents per share on October 31

Protara Therapeutics TARA Stock Earnings Reports
Q3'24
Est.
$-0.50
Q2'24
Beat
by $0.29
Q1'24
Missed
by $0.06
Q4'23
Beat
by $0.02
Q3'23
Beat
by $0.11
The last earnings report on August 06 showed earnings per share of -44 cents, beating the estimate of -74 cents. With 84.91K shares outstanding, the current market capitalization sits at 38.99M.
A.I. Advisor
published General Information

General Information

a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 646 844-0337
Employees
27
Web
http://www.protaratx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

TARA and Stocks

Correlation & Price change

A.I.dvisor tells us that TARA and VERA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TARA and VERA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
-4.00%
VERA - TARA
31%
Poorly correlated
+1.43%
PSTX - TARA
30%
Poorly correlated
N/A
ATYR - TARA
30%
Poorly correlated
-4.81%
CDXS - TARA
28%
Poorly correlated
-1.38%
PRME - TARA
28%
Poorly correlated
-9.81%
More